Biocytogen Pharmaceuticals (Beijing) Co., Ltd., announced that it has entered into an evaluation and option agreement with ADC Therapeutics SA. Biocytogen will grant ADC Therapeutics a license to evaluate Biocytogen
Found this useful? Share it with your team.
